Rescue pre-operative treatment with Lugol's solution in uncontrolled Graves' disease.
BACKGROUND
Graves' disease is a common cause of hyperthyroidism. Three therapies have been used for decades: pharmacologic therapy, surgery and radioiodine. In case of adverse events, especially agranulocytosis or hepatotoxicity, pre-treatment with Lugol's solution containing iodine/potassium iodide to induce euthyroidism before surgery could be advocated, but this has rarely been reported.


METHODS
All patients hospitalised due to uncontrolled hyperthyroidism at the Karolinska University Hospital 2005-2015 and treated with Lugol's solution were included. All electronic files were carefully reviewed manually, with focus on the cause of treatment and admission, demographic data, and effects of iodine on thyroid hormone levels and pulse frequency.


RESULTS
Twenty-seven patients were included. Lugol's solution had been chosen due to agranulocytosis in 9 (33%), hepatotoxicity in 2 (7%), other side effects in 11 (41%) and poor adherence to medication in 5 (19%). Levels of free T4, free T3 and heart rate decreased significantly after 5-9 days of iodine therapy (free T4 53-20 pmol/L,P= 0.0002; free T3 20-6.5 pmol/L,P= 0.04; heart rate 87-76 beats/minP= 0.0007), whereas TSH remained unchanged. Side effects were noted in 4 (15%) (rashn= 2, rash and vomitingn= 1, swelling of fingersn= 1). Thyroidectomy was performed in 26 patients (96%) and one was treated with radioiodine; all treatments were without serious complications.


CONCLUSIONS
Treatment of uncontrolled hyperthyroidism with Lugol's solution before definitive treatment is safe and it decreases thyroid hormone levels and heart rate. Side effects were limited. Lugol's solution could be recommended pre-operatively in Graves' disease with failed medical treatment, especially if side effects to anti-thyroid drugs have occurred.
Department of EndocrinologyMetabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden jan.calissendorff@sll.se.|Department of Molecular Medicine and SurgeryKarolinska Institutet, Stockholm, Sweden.
Jan
J
Calissendorff
Department of EndocrinologyMetabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden.|Department of Molecular Medicine and SurgeryKarolinska Institutet, Stockholm, Sweden.
Henrik
H
Falhammar
Graves’ disease; Lugol’s solution; hyperthyroidism; iodine; potassium iodide